Outlook Therapeutics's total assets for Q2 2025 were $19.08T, an increase of 112166500.56% from the previous quarter. OTLK total liabilities were $51.54T for the fiscal quarter, a 76582977.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.